Systematic review and meta-analysis of dropout rates in individual psychotherapy for generalized anxiety disorder

2017 ◽  
Vol 52 ◽  
pp. 25-33 ◽  
Author(s):  
Elon Gersh ◽  
David J. Hallford ◽  
Simon M. Rice ◽  
Nikolaos Kazantzis ◽  
Hannah Gersh ◽  
...  
Keyword(s):  
Systematic Review ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Meta Analysis ◽  
Dropout Rates ◽  
Generalized Anxiety ◽  
Individual Psychotherapy

scholarly journals The Prevalence of Generalized Anxiety Disorder Among Health Care Workers During the COVID-19 Pandemic: A Systematic Review and Meta-Analysis

2021 ◽  
Vol 12 ◽  
Author(s):  
Amir Adibi ◽  
Mohamad Golitaleb ◽  
Iman Farrahi-Ashtiani ◽  
Davoud Pirani ◽  
Kosar Yousefi ◽  
...  
Keyword(s):  
Systematic Review ◽  
Health Care ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Health Care Workers ◽  
Meta Analysis ◽  
Psychological Problems ◽  
Health Staff ◽  
Generalized Anxiety ◽  
Care Workers

Introduction: Health care workers, due to be involved in caring for COVID-19 patients may experience various psychological problems including anxiety disorders. This study aimed to investigate the prevalence of Generalized Anxiety Disorder (GAD) among health care workers during the COVID-19 pandemic by systematic review and meta-analysis.Methods: The PRISMA guideline was used for conducting this study. Related keywords were searched in credited resources including ISC, Magiran, PubMed, Scopus, Web of Science, Cochrane, ProQuest, Science Direct, Google Scholar, and Embase to find the articles published on the prevalence of GAD among health care workers during the COVID-19 pandemic from the first of January to the end of June 2020. Meta-analysis was conducted by the random effects model.Results: In this study, 553 articles were initially identified, from which 19 studies were finally included in the meta-analysis. The results showed that the prevalence of GAD in health care workers based on the GAD-7 and GAD-2 instruments were 32.04% (95% CI: 26.89–37.19, I2 = 98.2%, p < 0.001) and 22.62% (95% CI: 9.01–36.24, I2 = 97.7%, p < 0.001). The overall prevalence of GAD was obtained 30.5% (95% CI: 25.58–35.42, I2 = 98.4%, p < 0.001).Conclusion: This study showed a relatively high GAD prevalence, as one of the fundamental psychological problems, among health care workers during the COVID-19 pandemic. Therefore, health system managers should implement preventive strategies to protect health staff from contracting the virus and monitor them for psychological problems and provide them with supportive measures if necessary.

Review: Benzodiazepines in generalized anxiety disorder: heterogeneity of outcomes based on a systematic review and meta-analysis of clinical trials

2006 ◽  
Vol 21 (7) ◽  
pp. 774-782 ◽  
Author(s):  
Jose Luis R. Martin ◽  
Maria Sainz-Pardo ◽  
Toshiaki A. Furukawa ◽  
Eva Martin-Sanchez ◽  
Teresa Seoane ◽  
...  
Keyword(s):  
Systematic Review ◽  
Clinical Trials ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Meta Analysis ◽  
Generalized Anxiety

Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: A systematic review and meta-analysis

2015 ◽  
Vol 64 ◽  
pp. 88-98 ◽  
Author(s):  
Chi-Un Pae ◽  
Sheng-Min Wang ◽  
Changsu Han ◽  
Soo-Jung Lee ◽  
Ashwin A. Patkar ◽  
...  
Keyword(s):  
Systematic Review ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Meta Analysis ◽  
Generalized Anxiety

Influence of covariates on heterogeneity in Hamilton Anxiety Scale ratings in placebo-controlled trials of benzodiazepines in generalized anxiety disorder: Systematic review and meta-analysis

2019 ◽  
Vol 33 (5) ◽  
pp. 543-547
Author(s):  
Chris Gale ◽  
Paul Glue ◽  
Giuseppe Guaiana ◽  
John Coverdale ◽  
Maeve McMurdo ◽  
...  
Keyword(s):  
Systematic Review ◽  
Anxiety Disorder ◽  
Generalized Anxiety Disorder ◽  
Meta Analysis ◽  
Mean Difference ◽  
Anxiety Scale ◽  
Generalized Anxiety ◽  
Controlled Trials ◽  
Hamilton Anxiety Scale ◽  
Hamilton Anxiety

Background: Generalized anxiety disorder is a common psychiatric condition that is associated with decreased quality of life and significant disability. Benzodiazepines are anti-anxiety drugs used widely in the treatment of generalized anxiety disorder. This study examines the influence of several variables on benzodiazepine efficacy in generalized anxiety disorder. Method: We performed a systematic review of placebo-controlled randomized controlled trials with benzodiazepines in generalized anxiety disorder. Fifty-eight studies were deemed eligible to include in the meta-analysis. The studies dated from 1977 to 2013 and included over 5400 participants. From each paper, we extracted: benzodiazepine name and dose, dosing regimen, baseline Hamilton Anxiety Scale (HAM-A) score, change in HAM-A score at study endpoint, drop-out rate, year of study publication, diagnostic criteria used, study size, study duration, location, any conflicts of interest and side-effect profile. We then assessed the influence, direct and indirect, of individual variables on the primary outcome (mean difference at endpoint, HAM-A score). Results: Three factors were shown to be associated statistically with change in HAM-A; baseline HAM-A for benzodiazepine arm, baseline HAM-A for the placebo arm, and duration of the study. A higher baseline HAM-A in both arms was associated with a greater mean difference in HAM-A. A shorter study length was also associated with a greater mean difference. Discussion: The major factors determining benzodiazepine response was baseline anxiety level for the benzodiazepine arm and study duration. In any design of further meta-analyses and clinical trials for generalized anxiety disorder we suggest that these should be considered these as confounding factors.

Sign in / Sign up

Export Citation Format

Share Document